Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05576077
Title A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors (STARLING)
Acronym STARLING
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Turnstone Biologics, Corp.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.